9th Annual Pharmaceutical Strategic Outlook (PSO) Conference, April 11-13, 2012
“The Gold Sheet” January 2012, Vol. 46, No. 1
Word Count: 275 / Article # 08120126002
Join us at PSO 2012 where we will delve into the top issues affecting the pharma industry. Experience a dynamic three days of networking and discussion - with a personal and interactive setting, in-depth on-stage interviews, thought-provoking panels, one-on-one partnering meetings and innovative company presentations by carefully selected biotech companies. Don’t miss the opportunity to meet with potential partners, uncover licensing opportunities, and network with industry colleagues - including investors, venture capitalists, big pharma and biotech executives!
Register Now!
Receive $400 off when you register before February 3, 2012
Apply to Present!
Interested in becoming a presenter at the best networking conference? This year's conference agenda is designed to highlight only a select few presenting companies. Time slots will not compete with panel discussions.
Register now and hear compelling discussions on hot topics such as:
- Compensating the Dealmakers: "Am I Over or Underpaid?"
- Debate: The Runners and Riders in the Race for the Next Blockbuster
- More from Less: Optimizing the R&D Budget
- The Next Big Opportunity: Picking the Lottery Numbers
- Creative Deal Structures: 2010/2011 Winners
- Outlicensing: Stepping Stone or Exit?
Stellar line up of speakers include:
- Samuel Waksal, PhD, Chairman & CEO, Kadmon Pharmaceuticals
- Jeffrey Jonas, Senior Vice President R&D, Shire Pharmaceuticals
- Julian Adams, PhD, President, Research & Development, Infinity Pharmaceuticals
- Bob Baltera, CEO, Amira
- Elaine Caughey, Senior Director, Business Development, Biogen Idec
- Robert DeBenedetto, President & CEO, SFJ Pharmaceuticals
- Ron Laufer MD, MPH, Senior Managing Director, MedImmune Ventures
- Colin Goddard, CEO, OSI Pharmaceuticals
- Gene Mancino, Partner, Mancino Burfield Edgerton